ATAXIA-TELANGIECTASIA (A-T)

Clinical trials for ATAXIA-TELANGIECTASIA (A-T) explained in plain language.

Never miss a new study

Get alerted when new ATAXIA-TELANGIECTASIA (A-T) trials appear

Sign up with your email to follow new studies for ATAXIA-TELANGIECTASIA (A-T), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Experimental drug offered to patients with rare neurological disease

Disease control AVAILABLE

This program provides access to an investigational drug called levacetylleucine for people with Ataxia-Telangiectasia (A-T), a rare and serious neurological disease. It's designed for patients who cannot participate in regular clinical trials and have no satisfactory alternative …

Matched conditions: ATAXIA-TELANGIECTASIA (A-T)

Sponsor: IntraBio Inc • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

ATAXIA-TELANGIECTASIA (A-T)

Get alerted when new ATAXIA-TELANGIECTASIA (A-T) trials appear

Experimental drug offered to patients with rare neurological disease